Hepatocyte isolation from resected benign tissues: Results of a 5-year experience

Table 1 Patient profile and isolated human hepatocyte viability, total cell yield and hepatocyte yield

No.	Sex	Age (yr)	Blood group	Disease	Tissue weight (g)	Warm ischemia time (min)	Hepatocyte (× 105/g)	Viability (%)
1	Male	48	O+	Hemangiomas	15	30	28.00	62
2	Male	52	A+	Hemangiomas	18	25	20.56	73
3	Female	23	A+	Calculus	21	25	12.86	69
4	Male	55	O+	Hemangiomas	26	30	18.08	65
5	Female	45	A+	Hemangiomas	27	25	51.85	76
6	Female	36	B+	Hemangiomas	32	15	65.63	85
7	Male	47	AB+	Calculus	38	10	71.05	92
8	Male	42	A+	Hemangiomas	42	10	54.76	86
9	Male	52	A+	Hemangiomas	20	5	63.30	87
10	Male	63	O+	Hemangiomas	33	25	72.11	93
11	Female	46	O+	Hemangiomas	27	20	43.70	68
12	Male	57	A+	Hemangiomas	30	35	55.21	75
13	Male	44	B+	Calculus	25	15	63.81	84
14	Male	61	A+	Calculus	17	5	25.20	86
15	Female	57	A+	Hemangiomas	32	7	62.50	89
16	Male	27	A+	Hemangiomas	27	15	52.65	76
17	Female	55	B+	Calculus	23	7	32.07	66
18	Male	61	O+	Hemangiomas	31	25	68.80	90
19	Male	37	B+	Hemangiomas	37	21	72.22	92
20	Male	65	B+	Calculus	20	15	17.07	72
21	Male	79	O+	Calculus	26	20	22.51	66
22	Male	47	O+	Hemangiomas	35	5	67.72	89
23	Male	51	B+	Hemangiomas	24	12	59.27	77
24	Male	67	O+	Hemangiomas	30	17	62.25	82